Williamson Robert F III

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$333,389.55
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Williamson Robert F III

According to the SEC Form 4 filings, Williamson Robert F III, being in a position of

  1. director at Perspective Therapeutics, Inc.,
    оver the last 12 months, has bought 406378 shares for $333,390, and sold 0 shares,
    over all time since 2024-01-24, has bought 406378 shares for $333,390, and sold 0 shares.

The largest purchase of all time was on 2024-01-30 and amounted to 127206 shares of Perspective Therapeutics, Inc. for $90,710.

Biography of Williamson Robert F III

No biography is available at this moment.

2024-11-25PurchasePerspective Therapeutics, Inc.
CATX
director
6,266
0.0078%
$3.64$22,814+0.68%
2024-05-31PurchasePerspective Therapeutics, Inc.
CATX
director
55,000
0.0258%
$1.38$75,900-11.01%
2024-05-29PurchasePerspective Therapeutics, Inc.
CATX
director
30,031
0.0136%
$1.33$40,014-8.96%
2024-01-30PurchasePerspective Therapeutics, Inc.
CATX
director
127,206
0.0309%
$0.71$90,710+64.51%
2024-01-29PurchasePerspective Therapeutics, Inc.
CATX
director
25,266
0.0055%
$0.64$16,170+83.63%
2024-01-26PurchasePerspective Therapeutics, Inc.
CATX
director
110,613
0.0212%
$0.56$62,304+97.44%
2024-01-25PurchasePerspective Therapeutics, Inc.
CATX
director
22,134
0.0037%
$0.49$10,846+140.08%
2024-01-24PurchasePerspective Therapeutics, Inc.
CATX
director
29,862
0.005%
$0.49$14,632+152.35%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.